• Login
    View Item 
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of ChristieCommunitiesTitleAuthorsIssue DateSubmit DateSubjectsThis CollectionTitleAuthorsIssue DateSubmit DateSubjectsProfilesView

    My Account

    LoginRegister

    Local Links

    The Christie WebsiteChristie Library and Knowledge Service

    Statistics

    Display statistics

    Positron emission tomography of murine liver metastases and the effects of treatment by combretastatin A-4.

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Authors
    Zhao, Sha
    Moore, James V
    Waller, Michael L
    McGown, Alan T
    Hadfield, John A
    Pettit, G R
    Pettit, G R
    Hastings, David L
    Affiliation
    North West Medical Physics, Christie Hospital (NHS) Trust, Manchester, UK.
    Issue Date
    1999-03
    
    Metadata
    Show full item record
    Abstract
    There are major potential advantages in non-invasive measurement of preclinical tumour biology and therapeutic response in clinically relevant, internal body sites, notably the ability to follow outcome in individual animals rather than averaging results from groups. We have exploited positron emission tomography (PET) to determine the feasibility of detecting liver metastases in B6D2F1 mice using fluorine-18 fluorodeoxyglucose ([18F]FDG) both before and after treatment by the novel cytotoxic agent, combretastatin A-4. The normal distribution of [18F]FDG in the absence of disease was characterised, with the clear delineation of the brain, the heart and the urinary bladder in all studies. In untreated mice with liver metastases, a strong correlation (r2 = 0.98) was found between the quantitative estimates of [18F]FDG uptake obtained by analysis of PET images, and those obtained from ex vivo assay of liver plus metastases excised immediately after imaging. In this first series, the effective limit of resolution was in livers containing a number of small metastases (range 8-14) with a single volume equivalent of approximately 200 mm3. PET image analysis was concordant with histological measurements in showing that single intraperitoneal doses of combretastatin A-4 resulted in an average 30% volume destruction of metastatic mass by 24 h following administration.
    Citation
    Positron emission tomography of murine liver metastases and the effects of treatment by combretastatin A-4. 1999, 26 (3):231-8 Eur J Nucl Med
    Journal
    European Journal of Nuclear Medicine
    URI
    http://hdl.handle.net/10541/88040
    DOI
    10.1007/s002590050382
    PubMed ID
    10079313
    Type
    Article
    Language
    en
    ISSN
    0340-6997
    ae974a485f413a2113503eed53cd6c53
    10.1007/s002590050382
    Scopus Count
    Collections
    All Christie Publications

    entitlement

    Related articles

    • Feasibility of imaging photodynamic injury to tumours by high-resolution positron emission tomography.
    • Authors: Moore JV, Waller ML, Zhao S, Dodd NJ, Acton PD, Jeavons AP, Hastings DL
    • Issue date: 1998 Sep
    • More advantages in detecting bone and soft tissue metastases from prostate cancer using (18)F-PSMA PET/CT.
    • Authors: Pianou NK, Stavrou PZ, Vlontzou E, Rondogianni P, Exarhos DN, Datseris IE
    • Issue date: 2019 Jan-Apr
    • PET/CT in the evaluation of response to treatment of liver metastases from colorectal cancer with bevacizumab and irinotecan.
    • Authors: Goshen E, Davidson T, Zwas ST, Aderka D
    • Issue date: 2006 Feb
    • Noninvasive monitoring of tumor metabolism using fluorodeoxyglucose and positron emission tomography in colorectal cancer liver metastases: correlation with tumor response to fluorouracil.
    • Authors: Findlay M, Young H, Cunningham D, Iveson A, Cronin B, Hickish T, Pratt B, Husband J, Flower M, Ott R
    • Issue date: 1996 Mar
    • 90Y microsphere treatment of unresectable liver metastases: changes in 18F-FDG uptake and tumour size on PET/CT.
    • Authors: Bienert M, McCook B, Carr BI, Geller DA, Sheetz M, Tutor C, Amesur N, Avril N
    • Issue date: 2005 Jul
    DSpace software (copyright © 2002 - 2025)  DuraSpace
    Quick Guide | Contact Us
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.